Non-interventional study to evaluate Arimidex in postmenopausal women with advanced breast cancer

Study identifier:NIS-ARO-HCH-2006/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

ARIMIDEX Study ( Non-interventional study to evaluate Arimidex in adjuvant therapy in partial or complete response or stabilized disease after first line chemotherapy in postmenopausal women with advanced breast cancer)

Medical condition

Advanced breast cancer

Phase

Healthy volunteers

Study drug

anastrozole

Sex

Female

Actual Enrollment

200

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Dec 2006

Primary Completion Date: -

Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=746&filename=CSR-NIS-ARO-HCH-2006-1.pdf
Download
CSR-NIS-ARO-HCH-2006-1.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Romania Medical Department Clinical Study

+40213176041

denissa.turneanu@astrazeneca.com